Evogene Ltd. (EVGN.TA)
ILA 452.0
(-3.85%)
ILA 452.0
(-3.85%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 22.41 Million USD | 5.06% |
| 2022 | 21.33 Million USD | 65.6% |
| 2021 | 12.88 Million USD | -14.3% |
| 2020 | 15.03 Million USD | 34.86% |
| 2019 | 11.14 Million USD | 32.89% |
| 2018 | 8.38 Million USD | 1.99% |
| 2017 | 8.22 Million USD | -5.44% |
| 2016 | 8.69 Million USD | -1.65% |
| 2015 | 8.84 Million USD | -23.13% |
| 2014 | 11.5 Million USD | -8.44% |
| 2013 | 12.56 Million USD | -24.3% |
| 2012 | 16.59 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 21.39 Million USD | -4.55% |
| 2024 Q2 | 21.02 Million USD | -1.72% |
| 2023 Q2 | 22.23 Million USD | 5.96% |
| 2023 FY | 22.41 Million USD | 5.06% |
| 2023 Q1 | 20.98 Million USD | -1.67% |
| 2023 Q4 | 22.41 Million USD | 2.44% |
| 2023 Q3 | 21.88 Million USD | -1.57% |
| 2022 Q3 | 21.09 Million USD | 87.22% |
| 2022 Q1 | 12.15 Million USD | -5.7% |
| 2022 Q2 | 11.26 Million USD | -7.28% |
| 2022 FY | 21.33 Million USD | 65.6% |
| 2022 Q4 | 21.33 Million USD | 1.17% |
| 2021 Q2 | 10.89 Million USD | 2.06% |
| 2021 Q4 | 12.88 Million USD | 2.02% |
| 2021 Q3 | 12.62 Million USD | 15.93% |
| 2021 Q1 | 10.67 Million USD | -29.0% |
| 2021 FY | 12.88 Million USD | -14.3% |
| 2020 Q1 | 9.7 Million USD | -12.91% |
| 2020 Q2 | 10.13 Million USD | 4.37% |
| 2020 Q4 | 15.03 Million USD | 51.62% |
| 2020 Q3 | 9.91 Million USD | -2.14% |
| 2020 FY | 15.03 Million USD | 34.86% |
| 2019 FY | 11.14 Million USD | 32.89% |
| 2019 Q2 | 10.59 Million USD | -2.61% |
| 2019 Q4 | 11.14 Million USD | 8.13% |
| 2019 Q3 | 10.3 Million USD | -2.71% |
| 2019 Q1 | 10.88 Million USD | 29.71% |
| 2018 Q1 | 7.7 Million USD | -6.35% |
| 2018 Q2 | 8.13 Million USD | 5.65% |
| 2018 Q4 | 8.38 Million USD | 6.3% |
| 2018 Q3 | 7.89 Million USD | -3.02% |
| 2018 FY | 8.38 Million USD | 1.99% |
| 2017 Q2 | 8.11 Million USD | -5.62% |
| 2017 FY | 8.22 Million USD | -5.44% |
| 2017 Q3 | 8.1 Million USD | -0.14% |
| 2017 Q4 | 8.22 Million USD | 1.53% |
| 2017 Q1 | 8.59 Million USD | -1.18% |
| 2016 Q2 | 8.24 Million USD | 7.16% |
| 2016 FY | 8.69 Million USD | -1.65% |
| 2016 Q4 | 8.69 Million USD | 2.28% |
| 2016 Q3 | 8.5 Million USD | 3.12% |
| 2016 Q1 | 7.69 Million USD | -12.98% |
| 2015 Q1 | 9.75 Million USD | -15.19% |
| 2015 FY | 8.84 Million USD | -23.13% |
| 2015 Q2 | 9.5 Million USD | -2.53% |
| 2015 Q3 | 8.27 Million USD | -12.98% |
| 2015 Q4 | 8.84 Million USD | 6.86% |
| 2014 Q4 | 11.5 Million USD | 21.4% |
| 2014 Q3 | 9.47 Million USD | -5.5% |
| 2014 Q2 | 10.02 Million USD | -0.08% |
| 2014 Q1 | 10.03 Million USD | -20.12% |
| 2014 FY | 11.5 Million USD | -8.44% |
| 2013 Q3 | 13.25 Million USD | -9.85% |
| 2013 FY | 12.56 Million USD | -24.3% |
| 2013 Q1 | 14.64 Million USD | -11.77% |
| 2013 Q2 | 14.7 Million USD | 0.43% |
| 2013 Q4 | 12.56 Million USD | -5.23% |
| 2012 FY | 16.59 Million USD | 0.0% |
| 2012 Q4 | 16.59 Million USD | 5.97% |
| 2012 Q2 | 17.01 Million USD | 0.0% |
| 2012 Q3 | 15.66 Million USD | -7.96% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Matricelf Ltd | 3.7 Million ILA | -505.838% |